STATINS USE IN INRACEREBRAL HEMORRHAGE PATIENTS (SATURN)
This is a multi-center, pragmatic, prospective, randomized, open-label, and blinded end-point assessment (PROBE) clinical trial. A total of 1,456 patients presenting within 7 days of a spontaneous lobar ICH while taking statins will be randomized to one of two treatment strategies: discontinuation vs. continuation (restarting) of statin therapy (using the same agent and dose that they were using at ICH onset). Randomization will take into account: clinical site, statin dose and indication (primary vs. secondary prevention), current use and intent-to-use oral anticoagulants (OAC) and/or antiplatelets in the long-term post-ICH, and severity of ICH upon presentation as assessed by baseline ICH volume.Participating subjects will undergo baseline testing for APOE genotype and will be followed for 24 months to assess for the occurrence of recurrent symptomatic ICH or MACCE during the follow-up period.
Stem Cell Transplantation for Acute Lymphoblastic Leukemia | NYU Langone Health
NYU Langone doctors may recommend a stem cell transplant to treat acute lymphoblastic leukemia that is likely to recur.
Stem Cell Transplantation for Acute Myeloid Leukemia | NYU Langone Health
Doctors at NYU Langone recommend stem cell transplantation, also called bone marrow transplant, for some people with acute myeloid leukemia.
Stem Cell Transplantation for AIDS-Related Lymphoma | NYU Langone Health
NYU Langone doctors may recommend a stem cell transplant to manage AIDS-related lymphoma that returns after treatment.
Stem Cell Transplantation for Chronic Myelogenous Leukemia | NYU Langone Health
If chemotherapy drugs are not effective, NYU Langone doctors may recommend stem cell transplantation for chronic myelogenous leukemia.
Stem Cell Transplantation for Cutaneous T-Cell Lymphoma | NYU Langone Health
NYU Langone doctors may use stem cell transplantation for cutaneous T-cell lymphoma that does not respond to other therapies.
Stem Cell Transplantation for Hodgkin Lymphoma | NYU Langone Health
NYU Langone doctors may recommend stem cell transplantation for some people with Hodgkin lymphoma.
Stem Cell Transplantation for Leukemia in Children | NYU Langone Health
Doctors at Hassenfeld Children’s Hospital at NYU Langone may recommend stem cell transplantation to treat childhood leukemia.
Stem Cell Transplantation for Multiple Myeloma | NYU Langone Health
NYU Langone doctors may use stem cell transplantation to treat multiple myeloma that is more advanced.
Stem Cell Transplantation for Myelodysplastic Syndromes | NYU Langone Health
NYU Langone doctors may recommend stem cell transplantation for people with high-risk myelodysplastic syndromes.